Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-25T00:51:11.242Z Has data issue: false hasContentIssue false

31 - Transmissible spongiform encephalopathies (CJD and vCJD)

Published online by Cambridge University Press:  07 December 2009

Goura Kudesia
Affiliation:
Sheffield Teaching Hospital NHS Foundation Trust
Tim Wreghitt
Affiliation:
Addenbrooke's Hospital, Cambridge
Get access

Summary

Transmissible spongiform encephalopathies (TSE) are a group of agents that give rise to spongiform degeneration in the brain. These agents do not possess any nucleic acid (DNA or RNA) and are very resistant to inactivation. They consist of only a glycoprotein core and the term prion or prion protein (PrP) has been coined to describe them. They infect both humans and animals, and have recently been shown to cross the species barrier, e.g. vCJD crossed into humans from cattle. See Table 31.1.

Epidemiology

The first agent to be described was scrapie. Scrapie has been known to cause infection in sheep in the UK for more than a hundred years. In the late 1980s and 1990s there was an outbreak of a bovine form of scrapie, namely bovine spongiform encephalopathy (BSE), which had previously not been described. This led to destruction of thousands of cattle in the UK and a public health crisis in the confidence of beef for human consumption.

Creutzfeldt–Jakob disease (CJD) is the human form of prion disease, and has been known to occur throughout the world since 1920. Kuru is the name given to the infection that was limited to only parts of Papua New Guinea. In the 1990s, a new form of CJD was described for the first time in the UK as a result of BSE transmission; this was named as variant CJD (vCJD) to distinguish it from the already existing CJD.

Human prion disease can be acquired through either an inherited or an infectious route.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×